Enzychem Lifesciences Corp (183490) Stock Price & News

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	16.40B	16.47B	14.10B	14.89B
Cost of goods sold	15.60B	16.04B	13.54B	14.55B
Cost of revenue	15.60B	16.04B	13.54B	14.55B
Research and development expenses	856.35M	817.65M	800.90M	688.59M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.01B	2.88B	4.15B	2.89B
Operating expense	4.48B	4.15B	8.87B	3.04B
Total operating expenses	20.08B	20.18B	22.42B	17.59B
Operating income	-3.68B	-3.71B	-8.32B	-2.70B
Other non operating income	378.79M	-351.89M	1.42B	1.63M
EBT including unusual items	-3.03B	-3.31B	-10.07B	-1.89B
EBT excluding unusual items	-3.00B	-3.20B	-6.33B	-1.89B
Income tax expense	-2.29M	-6.27M	-128.45M	6.48M
Effective tax rate	0.08%	0.19%	1.28%	-0.34%
Other operating expenses	-	-	-	-
Net income	-3.06B	-3.31B	-9.90B	-1.86B
Net profit margin	-18.64%	-20.07%	-70.24%	-12.46%
Earnings per share	-	-	-	-
Interest and investment income	961.15M	939.29M	870.94M	883.67M
Interest expense	-54.74M	-44.39M	-44.22M	-45.87M
Net interest expenses	906.41M	894.89M	826.72M	837.81M
Depreciation and amortization charges	130.53M	104.82M	105.64M	103.72M
EBITDA	-2.88B	-2.95B	-7.58B	-2.16B
Gain or loss from assets sale	30.01M	86.36M	9.06M	1.06M

AI content may include mistakes. Learn more

Finance